SK’s Post

Ypsomed’s latest article, published in ONdrugDelivery 😊, explores the latest advancements in self-injection technology, focusing on solutions for high-volume, high-viscosity drug formulations . 📣 How does the YpsoDose patch injector address the challenge of minimizing drug formulation loss and ensuring consistent flow rates? 📣 What are the key features of the YpsoMate 5.5 that make it suitable for high-volume and high-viscosity drug delivery? 📣 What innovations has Ypsomed introduced to accommodate high-viscosity formulations and reduce injection time for patients? #Ypsomed #ONdrugDelivery #Selfcare #Medtech #LargeVolumeInjection

As our designated center of excellence for novel drug delivery systems, Innovaform™ Accelerator is where we help our customers tackle the challenges of oral and inhalable dosage formulation. In this spirit of partnership, we would like to share our latest briefing paper with you. It gives you the key takeaways from the UNGAP network opinion on current intestinal drug absorption research — and where researchers should focus their efforts next. Read the paper here: https://lnkd.in/dFzkWhrV #Innovation #Capsules #PharmaceuticalManufacturing #DrugAbsorption

As our designated center of excellence for novel drug delivery systems, Innovaform™ Accelerator is where we help our customers tackle the challenges of oral and inhalable dosage formulation. In this spirit of partnership, we would like to share our latest briefing paper with you. It gives you the key takeaways from the UNGAP network opinion on current intestinal drug absorption research — and where researchers should focus their efforts next. Read the paper here: https://lnkd.in/dKqUg5bi #Innovation #Capsules #PharmaceuticalManufacturing #DrugAbsorption

As our designated center of excellence for novel drug delivery systems, Innovaform™ Accelerator is where we help our customers tackle the challenges of oral and inhalable dosage formulation. In this spirit of partnership, we would like to share our latest briefing paper with you. It gives you the key takeaways from the UNGAP network opinion on current intestinal drug absorption research — and where researchers should focus their efforts next. Read the paper here: https://lnkd.in/dETsmQSm #Innovation #Capsules #PharmaceuticalManufacturing #DrugAbsorption

𝗠𝗠𝗖 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗮𝘁 𝗗𝗗𝗙 𝗦𝘂𝗺𝗺𝗶𝘁 Day 1 is already filled with great insights thanks to Natasha Bank and Peter Åsberg from Disruptive Pharma AB and their poster „𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝗱 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝘂𝘁𝗶𝗹𝗶𝘇𝗶𝗻𝗴 𝗠𝗠𝗖 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 - 𝗔𝗺𝗼𝗿𝗽𝗼𝘂𝘀 𝗱𝗿𝘂𝗴 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀, 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗯𝗶𝗼𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗶𝗺𝗽𝗿𝗼𝘃𝗲𝗱 𝘀𝗮𝗳𝗲𝘁𝘆“. There is so much more to be learned about the opportunities mesoporous magnesium stearate (MMC) can offer the drug product formulators. #excipients #formulation #drugdelivery

At Nanopharm, our expertise in developing intranasal and inhaled drug products sets us apart. We’ve pioneered in-silico technologies that accelerate and derisk OINDP development. One standout is our in-vitro Bioequivalence platform (IVBE). Our specialized platforms evaluate key physicochemical properties and device performance, ensuring that API, formulation, and device deliver bioequivalence for patients. We adhere to major regulatory requirements and offer alternative non-clinical pathways to demonstrate bioequivalence using in-vitro tests. These tests, combined with new in-silico tools, allow us to predict pharmacodynamic and pharmacokinetic performance without clinical studies. Our advanced in-vitro bioequivalence capabilities streamline the path to market for new OINDP products, bringing them efficiently to the patients who need them most. Learn more about our cutting-edge solutions - https://lnkd.in/dZkvuSFT #Nanopharm #InhaledDrugDevelopment #IntranasalDrugDevelopment #Bioequivalence #InVitroBioequivalenc

YpsoMate On he integrated connectivity of YpsoMate On automatically logs injections & provides users a visual end of injection feedback directly on the device. https://lnkd.in/d8XMUUuc #packaging #pharma #bio #injection #technology #medicine

Great article in this month's issue of Drug Development & Delivery featuring cyclodextrins and other solubilization techniques. Ardena's Drug Product team, led by Vincent Levet (Director, Formulation Development and Production) and Timothy Pas (Group Leader, Formulation Development and Production), has just published this technical article that explores innovative formulation strategies aimed at addressing solubility and bioavailability challenges in poorly soluble drugs. With a focus on advanced techniques like #AmorphousSolidDispersions (ASDs), #LipidBased formulations, #Nanosuspensions, and #Cyclodextrin complexes. The team highlights how these approaches can accelerate time-to-market while ensuring optimal therapeutic outcomes. 📖 Read the full article below or directly at the link: https://lnkd.in/di8EtzrR

Explore the benefits of Ashwagandha capsules by Jagat Pharma in this video testimonial. Learn about its uses and how it can enhance your well-being. Watch here : https://lnkd.in/gGreAegN #AshwagandhaBenefits #JagatPharma #HerbalHealth #AyurvedicWellness

Are Dry Powder Inhalers the Final Answer ? Dry powder inhalers (DPIs) are often highlighted as a propellant-free alternative to pMDIs. However, their usability and patient experience often fall short of expectations compared to soft mist inhalers (SMIs). SMIs deliver a similar experience to pMDIs while eliminating the environmental cost of propellants, making them a preferred choice for many. As companies like MERXIN Ltd and Lupin Pharmaceuticals innovate in this space, the role of high-performance biomaterials like the Pharmaceutical Victrex PEEK polymers becomes increasingly critical. These materials enable robust, reusable designs that meet patient needs while supporting global sustainability goals. What innovations in materials and design do you think will define the next generation of respiratory devices ? Join the conversation ahead of #RESCON USA 2024!"" #RESCON24 #respiratory #pharmaceutical #PEEK #medicaldevices"